Antonio Rosario Gargiulo, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leiomyoma | 18 | 2023 | 730 | 3.780 |
Why?
|
| Gynecologic Surgical Procedures | 10 | 2023 | 336 | 3.190 |
Why?
|
| Laparoscopy | 25 | 2023 | 2151 | 3.170 |
Why?
|
| Uterine Neoplasms | 19 | 2023 | 1513 | 2.990 |
Why?
|
| Infertility, Female | 13 | 2023 | 787 | 2.180 |
Why?
|
| Robotics | 10 | 2024 | 899 | 2.120 |
Why?
|
| Uterus | 9 | 2023 | 711 | 1.960 |
Why?
|
| Reproductive Rights | 2 | 2018 | 35 | 1.240 |
Why?
|
| Surgery, Computer-Assisted | 5 | 2019 | 1018 | 0.940 |
Why?
|
| Hysterectomy | 6 | 2023 | 927 | 0.910 |
Why?
|
| Lasers, Gas | 2 | 2015 | 93 | 0.910 |
Why?
|
| Hysteroscopy | 2 | 2023 | 102 | 0.730 |
Why?
|
| Endometriosis | 4 | 2023 | 839 | 0.670 |
Why?
|
| Laparotomy | 3 | 2018 | 473 | 0.660 |
Why?
|
| Laser Therapy | 2 | 2015 | 1072 | 0.610 |
Why?
|
| Organ Transplantation | 2 | 2018 | 1139 | 0.610 |
Why?
|
| Reproductive Medicine | 2 | 2018 | 108 | 0.580 |
Why?
|
| Reproduction | 3 | 2019 | 668 | 0.510 |
Why?
|
| Genital Diseases, Female | 1 | 2016 | 197 | 0.490 |
Why?
|
| Myometrium | 2 | 2014 | 181 | 0.480 |
Why?
|
| Electrosurgery | 1 | 2014 | 58 | 0.480 |
Why?
|
| Clinical Competence | 3 | 2019 | 4687 | 0.470 |
Why?
|
| Public Opinion | 1 | 2018 | 477 | 0.470 |
Why?
|
| Uterine Artery Embolization | 2 | 2023 | 62 | 0.430 |
Why?
|
| Blood Loss, Surgical | 5 | 2016 | 662 | 0.410 |
Why?
|
| Fertility | 2 | 2014 | 781 | 0.390 |
Why?
|
| Abdominal Cavity | 1 | 2011 | 52 | 0.380 |
Why?
|
| Functional Laterality | 1 | 2017 | 2290 | 0.370 |
Why?
|
| Oocyte Retrieval | 1 | 2011 | 161 | 0.350 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2011 | 118 | 0.350 |
Why?
|
| Ovarian Follicle | 1 | 2011 | 247 | 0.340 |
Why?
|
| Fertilization in Vitro | 6 | 2015 | 1284 | 0.320 |
Why?
|
| Microsurgery | 1 | 2014 | 796 | 0.320 |
Why?
|
| Endocrinology | 1 | 2014 | 443 | 0.320 |
Why?
|
| Female | 54 | 2023 | 380194 | 0.310 |
Why?
|
| Vagina | 1 | 2011 | 825 | 0.270 |
Why?
|
| Laparoscopes | 2 | 2015 | 41 | 0.260 |
Why?
|
| Gonadotropins, Pituitary | 1 | 2005 | 73 | 0.260 |
Why?
|
| Vasopressins | 2 | 2017 | 370 | 0.260 |
Why?
|
| Estradiol | 3 | 2005 | 2020 | 0.240 |
Why?
|
| Menstrual Cycle | 3 | 2004 | 551 | 0.240 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 3843 | 0.240 |
Why?
|
| Ovulation | 1 | 2004 | 189 | 0.230 |
Why?
|
| Cervix Uteri | 2 | 2004 | 590 | 0.220 |
Why?
|
| Embryo Implantation | 1 | 2004 | 272 | 0.220 |
Why?
|
| Equipment Design | 3 | 2015 | 3582 | 0.210 |
Why?
|
| Humans | 53 | 2024 | 744343 | 0.210 |
Why?
|
| Pregnancy | 14 | 2023 | 29144 | 0.180 |
Why?
|
| Gonadotropin-Releasing Hormone | 2 | 2016 | 1205 | 0.180 |
Why?
|
| Adult | 23 | 2023 | 214055 | 0.180 |
Why?
|
| Specimen Handling | 2 | 2015 | 694 | 0.180 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2004 | 370 | 0.180 |
Why?
|
| Pregnancy Outcome | 4 | 2015 | 2795 | 0.160 |
Why?
|
| Treatment Outcome | 11 | 2023 | 63114 | 0.160 |
Why?
|
| Tissue Adhesions | 2 | 2023 | 235 | 0.160 |
Why?
|
| Perception | 2 | 2018 | 1198 | 0.160 |
Why?
|
| Length of Stay | 3 | 2016 | 6309 | 0.150 |
Why?
|
| Cicatrix | 1 | 2023 | 764 | 0.150 |
Why?
|
| Progestins | 2 | 2016 | 306 | 0.150 |
Why?
|
| Metformin | 1 | 2004 | 835 | 0.140 |
Why?
|
| Postoperative Complications | 6 | 2023 | 15295 | 0.140 |
Why?
|
| Hemostasis, Surgical | 1 | 2016 | 128 | 0.130 |
Why?
|
| Goserelin | 1 | 2016 | 129 | 0.130 |
Why?
|
| History, 19th Century | 1 | 2018 | 720 | 0.130 |
Why?
|
| Tissue Preservation | 1 | 2016 | 182 | 0.130 |
Why?
|
| Progesterone | 5 | 2010 | 776 | 0.130 |
Why?
|
| Surgical Equipment | 1 | 2014 | 57 | 0.120 |
Why?
|
| Urologic Surgical Procedures | 1 | 2017 | 302 | 0.120 |
Why?
|
| Fertility Agents, Female | 2 | 2005 | 99 | 0.120 |
Why?
|
| Reproductive Techniques, Assisted | 2 | 2016 | 482 | 0.120 |
Why?
|
| Hemostatics | 1 | 2016 | 229 | 0.120 |
Why?
|
| Labor, Obstetric | 1 | 1997 | 333 | 0.110 |
Why?
|
| Retrospective Studies | 9 | 2023 | 77449 | 0.110 |
Why?
|
| Task Performance and Analysis | 1 | 2017 | 780 | 0.110 |
Why?
|
| Coloring Agents | 1 | 2015 | 566 | 0.110 |
Why?
|
| Attitude | 1 | 2018 | 776 | 0.110 |
Why?
|
| Bone Resorption | 1 | 1997 | 723 | 0.110 |
Why?
|
| Tumor Burden | 2 | 2015 | 1915 | 0.110 |
Why?
|
| Sus scrofa | 1 | 2014 | 437 | 0.110 |
Why?
|
| Patient-Centered Care | 1 | 2023 | 1439 | 0.110 |
Why?
|
| Leiomyomatosis | 1 | 2012 | 70 | 0.110 |
Why?
|
| History, 21st Century | 1 | 2018 | 1534 | 0.100 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 2029 | 0.100 |
Why?
|
| Sterilization Reversal | 1 | 2011 | 5 | 0.100 |
Why?
|
| Hypoglycemic Agents | 1 | 2004 | 2872 | 0.100 |
Why?
|
| Ovary | 1 | 2016 | 981 | 0.100 |
Why?
|
| Endometrium | 3 | 2004 | 424 | 0.100 |
Why?
|
| Tongue | 1 | 2014 | 406 | 0.100 |
Why?
|
| Learning Curve | 1 | 2012 | 208 | 0.090 |
Why?
|
| Embryo Transfer | 2 | 2023 | 510 | 0.090 |
Why?
|
| Cytokines | 2 | 2005 | 7322 | 0.090 |
Why?
|
| Desensitization, Immunologic | 2 | 2016 | 483 | 0.090 |
Why?
|
| Time Factors | 4 | 2015 | 40075 | 0.090 |
Why?
|
| History, 20th Century | 1 | 2018 | 2740 | 0.090 |
Why?
|
| Quality of Life | 3 | 2023 | 12804 | 0.080 |
Why?
|
| Forecasting | 1 | 2017 | 2951 | 0.080 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2023 | 3143 | 0.080 |
Why?
|
| Pregnancy Rate | 1 | 2011 | 643 | 0.080 |
Why?
|
| Drug Eruptions | 1 | 2010 | 297 | 0.080 |
Why?
|
| Placenta | 1 | 1997 | 1698 | 0.080 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2016 | 1524 | 0.080 |
Why?
|
| Tacrolimus | 1 | 2011 | 743 | 0.070 |
Why?
|
| Hypersensitivity | 1 | 2016 | 1102 | 0.070 |
Why?
|
| Cross-Sectional Studies | 2 | 2018 | 25043 | 0.070 |
Why?
|
| Middle Aged | 10 | 2019 | 213383 | 0.070 |
Why?
|
| Overweight | 2 | 2015 | 2371 | 0.070 |
Why?
|
| Mucins | 2 | 2001 | 564 | 0.070 |
Why?
|
| Kidney Neoplasms | 1 | 2023 | 4262 | 0.070 |
Why?
|
| Feasibility Studies | 1 | 2015 | 5078 | 0.060 |
Why?
|
| Treatment Failure | 1 | 2011 | 2618 | 0.060 |
Why?
|
| Neoadjuvant Therapy | 1 | 2016 | 2728 | 0.060 |
Why?
|
| Corpus Luteum | 2 | 1994 | 86 | 0.060 |
Why?
|
| Academic Medical Centers | 1 | 2015 | 2759 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2005 | 245 | 0.060 |
Why?
|
| Clomiphene | 1 | 2004 | 72 | 0.060 |
Why?
|
| Hirsutism | 1 | 2004 | 69 | 0.060 |
Why?
|
| Curriculum | 1 | 2017 | 3605 | 0.060 |
Why?
|
| Swine | 1 | 2014 | 5917 | 0.060 |
Why?
|
| Pregnancy Complications | 2 | 2015 | 2861 | 0.060 |
Why?
|
| Trophoblasts | 1 | 2005 | 215 | 0.060 |
Why?
|
| Osmolar Concentration | 1 | 2004 | 683 | 0.060 |
Why?
|
| Leuprolide | 1 | 2005 | 321 | 0.060 |
Why?
|
| Therapeutic Irrigation | 1 | 2004 | 301 | 0.060 |
Why?
|
| Wound Healing | 1 | 2014 | 2785 | 0.060 |
Why?
|
| Menstruation Disturbances | 1 | 2004 | 148 | 0.050 |
Why?
|
| Preimplantation Diagnosis | 1 | 2005 | 151 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2005 | 658 | 0.050 |
Why?
|
| Young Adult | 4 | 2018 | 56430 | 0.050 |
Why?
|
| Pediatrics | 1 | 2017 | 3475 | 0.050 |
Why?
|
| Cervix Mucus | 1 | 2001 | 18 | 0.050 |
Why?
|
| Prospective Studies | 7 | 2023 | 53288 | 0.050 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2001 | 185 | 0.050 |
Why?
|
| Glucose Tolerance Test | 1 | 2004 | 1150 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2011 | 21746 | 0.050 |
Why?
|
| Hormones | 1 | 2004 | 889 | 0.050 |
Why?
|
| Amenorrhea | 1 | 2004 | 485 | 0.050 |
Why?
|
| Th2 Cells | 1 | 2005 | 1061 | 0.040 |
Why?
|
| United States | 2 | 2018 | 69872 | 0.040 |
Why?
|
| Glutamine | 1 | 2023 | 578 | 0.040 |
Why?
|
| Live Birth | 1 | 2023 | 512 | 0.040 |
Why?
|
| Translocation, Genetic | 1 | 2005 | 1420 | 0.040 |
Why?
|
| Placebos | 1 | 2004 | 1676 | 0.040 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2001 | 599 | 0.040 |
Why?
|
| Living Donors | 1 | 2023 | 620 | 0.040 |
Why?
|
| Colpotomy | 1 | 2018 | 14 | 0.040 |
Why?
|
| Male | 6 | 2023 | 350118 | 0.040 |
Why?
|
| Obesity | 2 | 2015 | 12745 | 0.040 |
Why?
|
| RNA, Messenger | 3 | 2004 | 13033 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2011 | 4149 | 0.040 |
Why?
|
| Microdialysis | 2 | 1994 | 158 | 0.040 |
Why?
|
| Luteal Phase | 2 | 1995 | 147 | 0.040 |
Why?
|
| Graft Rejection | 1 | 2011 | 4397 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2011 | 5985 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2015 | 12720 | 0.040 |
Why?
|
| Benchmarking | 1 | 2024 | 1042 | 0.040 |
Why?
|
| Nephrectomy | 1 | 2023 | 1050 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2005 | 2007 | 0.040 |
Why?
|
| Reference Values | 1 | 2004 | 4982 | 0.040 |
Why?
|
| Chorion | 1 | 1997 | 117 | 0.040 |
Why?
|
| Decidua | 1 | 1997 | 86 | 0.040 |
Why?
|
| Anxiety | 1 | 2011 | 4297 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2011 | 3923 | 0.030 |
Why?
|
| Intraoperative Complications | 1 | 2023 | 1198 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 35421 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 2011 | 4251 | 0.030 |
Why?
|
| Adolescent | 4 | 2016 | 85781 | 0.030 |
Why?
|
| Amnion | 1 | 1997 | 209 | 0.030 |
Why?
|
| Fertilization | 1 | 2015 | 196 | 0.030 |
Why?
|
| Uterine Diseases | 1 | 2015 | 135 | 0.030 |
Why?
|
| Pregnancy, Animal | 1 | 1994 | 134 | 0.030 |
Why?
|
| Diabetes, Gestational | 1 | 2004 | 1184 | 0.030 |
Why?
|
| Epidermal Growth Factor | 1 | 1997 | 708 | 0.030 |
Why?
|
| Child | 2 | 2023 | 77709 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2004 | 6489 | 0.030 |
Why?
|
| Periodicity | 1 | 1994 | 363 | 0.030 |
Why?
|
| Animals | 6 | 2023 | 168757 | 0.030 |
Why?
|
| Placenta Diseases | 1 | 2015 | 199 | 0.030 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1995 | 744 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2022 | 2240 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 10943 | 0.030 |
Why?
|
| Weight Loss | 1 | 2004 | 2622 | 0.030 |
Why?
|
| Life Style | 1 | 2004 | 3835 | 0.030 |
Why?
|
| Sheep | 1 | 1994 | 1437 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2005 | 2988 | 0.020 |
Why?
|
| Infant, Low Birth Weight | 1 | 2015 | 850 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2024 | 6196 | 0.020 |
Why?
|
| Estrogen Replacement Therapy | 1 | 1997 | 1203 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2011 | 6365 | 0.020 |
Why?
|
| Mucin-5B | 2 | 2001 | 141 | 0.020 |
Why?
|
| Italy | 1 | 2011 | 832 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2023 | 12026 | 0.020 |
Why?
|
| Aged | 3 | 2018 | 163280 | 0.020 |
Why?
|
| Cattle | 1 | 2014 | 3922 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2004 | 7913 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 2011 | 968 | 0.020 |
Why?
|
| Exercise | 1 | 2004 | 5615 | 0.020 |
Why?
|
| Registries | 1 | 2023 | 8089 | 0.020 |
Why?
|
| Cell Membrane | 1 | 1997 | 3748 | 0.020 |
Why?
|
| Truth Disclosure | 1 | 2011 | 436 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1994 | 2015 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 19905 | 0.020 |
Why?
|
| Amniocentesis | 1 | 2005 | 116 | 0.020 |
Why?
|
| Nuchal Translucency Measurement | 1 | 2005 | 56 | 0.020 |
Why?
|
| Drug Monitoring | 1 | 2011 | 956 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2015 | 40561 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2011 | 4933 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2001 | 12072 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2001 | 4751 | 0.010 |
Why?
|
| Pain | 1 | 1997 | 4986 | 0.010 |
Why?
|
| Genetic Counseling | 1 | 2005 | 600 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2014 | 8324 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2011 | 6038 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2005 | 1057 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2004 | 11725 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 2886 | 0.010 |
Why?
|
| Mucin-4 | 1 | 1999 | 37 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 2005 | 1607 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2001 | 1095 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 2010 | 2133 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 2005 | 1813 | 0.010 |
Why?
|
| Heterozygote | 1 | 2005 | 2804 | 0.010 |
Why?
|
| Luteinizing Hormone | 1 | 2001 | 869 | 0.010 |
Why?
|
| beta 2-Microglobulin | 1 | 1999 | 315 | 0.010 |
Why?
|
| Fetus | 1 | 2005 | 1880 | 0.010 |
Why?
|
| Pedigree | 1 | 2005 | 4644 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 2001 | 18111 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1999 | 798 | 0.010 |
Why?
|
| Saliva | 1 | 2001 | 809 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 18029 | 0.010 |
Why?
|
| Sheep Diseases | 1 | 1994 | 18 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2015 | 25625 | 0.010 |
Why?
|
| Streptozocin | 1 | 1994 | 196 | 0.010 |
Why?
|
| Epitopes | 1 | 2001 | 2571 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1994 | 554 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1994 | 919 | 0.010 |
Why?
|
| Epithelium | 1 | 1999 | 1679 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2001 | 3870 | 0.010 |
Why?
|
| Pregnancy in Diabetics | 1 | 1994 | 179 | 0.010 |
Why?
|
| Papio | 1 | 1994 | 656 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1995 | 1681 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2001 | 4217 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2001 | 6459 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 39050 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1994 | 1472 | 0.010 |
Why?
|
| Mice | 1 | 1997 | 81183 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2001 | 13815 | 0.010 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 1994 | 1116 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 11366 | 0.000 |
Why?
|
| Biopsy | 1 | 1995 | 6756 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2001 | 57776 | 0.000 |
Why?
|